Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Peter Singleton who wrote (5435)	8/6/1998 8:31:00 PM
From: Pseudo Biologist	Read Replies (1) \| Respond to of 9719

Re: Asia and Isis Peter, from the "Blood" thread in case you missed it: Message 5433154 Interesting comments about China. On Isis, following up on the discussion started on the AGPH thread: the work you cite is very interesting (https://www.siliconinvestor.com/readmsg.aspx?msgid=5429724 ). I was a bit aware of it, but was not what I had in mind initially. Yes, this type of patent claim may be more likely to create some conflict with the prophetic claims routinely made by genomics work. The latter implicitly assumes that design of optimal antisense agents (at least as far as choice of which 15-20 bp stretch to target) is "obvious." The Isis work you mentioned tries to show otherwise, and then teaches how to go about getting that "optimal" design for specific cases. Are we back to the TV tube and TV set analogy? Rocketman, your turn. PB